Zobrazeno 1 - 4
of 4
pro vyhledávání: '"James H. Bordelon"'
Autor:
Hyman B. Muss, Stephen E. Jones, Donald A. Richards, James H. Bordelon, Joanne L. Blum, Svetislava J. Vukelja, Kristi J. McIntyre, John Pippen, Joyce O'Shaughnessy, Stefan Riedel, Frankie A. Holmes, Robert Kirby, Lina Asmar, Daniel Mackey, Wally G. Meyer, Robert G. Mennel, Kristi A. Boehm, John Sandbach, William J. Hyman, Michael Savin
Publikováno v:
Journal of Clinical Oncology. 27:1177-1183
Purpose We previously reported that four cycles of docetaxel/cyclophosphamide (TC) produced superior disease-free survival (DFS) compared with four cycles of doxorubicin/cyclophosphamide (AC) in early breast cancer. Older women are under-represented
Autor:
Jennifer C. Davis, Robert Darren Brooks, Frankie A. Holmes, Ragene Rivera, Steven J. Ketchel, Nicole L. Hartung, Lina Asmar, Joanne L. Blum, Jean Kochis, Sreeni Chittoor, Donald A. Richards, Des Ilegbodu, Thomas Whittaker, Angel G. Negron, John Pippen, Stephen E. Jones, J. Cantrell, James H. Bordelon, Svetislava J. Vukelja, Joyce O'Shaughnessy
Publikováno v:
Journal of Clinical Oncology. 25:4765-4771
Purpose Hormonal breast cancer treatment increases menopausal symptoms in women. This study investigated differences between the symptoms associated with either adjuvant tamoxifen or exemestane. Patients and Methods Ten common symptoms were assessed
Autor:
Stephen P. Anthony, Joanne L. Blum, Angel G. Negron, John Pippen, Pankaj Khandelwal, Donald A. Richards, Walter G. Meyer, Kristi J. McIntyre, James H. Bordelon, Stephen E. Jones, John Sandbach, Lina Asmar, William J. Hyman, Joyce O'Shaughnessy, Robert Kirby, Kristi A. Boehm, Frankie A. Holmes, Michael Savin, Robert G. Mennel, Svetislava J. Vukelja
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(34)
PurposeThe combination of doxorubicin and cyclophosphamide (AC) is a standard adjuvant chemotherapy regimen. Studies of docetaxel and cyclophosphamide (TC) in metastatic breast cancer (MBC) showed promise in MBC. In 1997, we initiated a randomized ad
Publikováno v:
Journal of Maxillofacial Surgery. 8:187-194
Medical advances in the care of individuals with sickle cell disease have progressed to the level where elective surgical procedures can be performed. Successful management of these individuals requires understanding of the pathophysiology of the dis